TrialAdvances in therapy2023

B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus Infection.

Jennifer Cremer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.